{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:33:57Z","timestamp":1772120037054,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004695","name":"University of KwaZulu-Natal","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004695","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Community Genet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Confirming a genetic diagnosis of cystic fibrosis (CF) for clinically affected individuals should be more accessible today, with more laboratories offering testing and improved technologies at lower costs. Instead, diagnostic testing for CF has become more complex due to the variety of genetic testing options available for the one known causative gene (\n                    <jats:italic>CFTR<\/jats:italic>\n                    ). This article provides an overview of genetic tests currently available for CF in six laboratories in South Africa. Also, it demonstrates the evolution of CF tests used at one private laboratory in the country via a ten-year retrospective study. The findings of this study may serve as a guide for healthcare providers in selecting appropriate testing for CF diagnostic or carrier genetic confirmation. The choice of genetic test and methodology depends on individualised factors such as the ethnic origin of the patient, test availability, advantages and limitations, and cost. The ethnic diversity of South Africa\u2019s populations and probable under-reporting of CF in the country make the diagnosis of this relatively common genetic condition complex. The actual burden of CF in South Africa is unknown, and comprehensive genetic testing, with an ongoing compilation of patient data in the South African CF registry, should assist in addressing the genetic diversity of CF-causing variants.\n                  <\/jats:p>","DOI":"10.1007\/s12687-025-00810-6","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:51:30Z","timestamp":1758790290000},"page":"827-838","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From past to progress: a retrospective study on CFTR genetic testing in South Africa"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4239-7897","authenticated-orcid":false,"given":"Sarah","family":"Walters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7199-9160","authenticated-orcid":false,"given":"Colleen","family":"Aldous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9566-6248","authenticated-orcid":false,"given":"Helen","family":"Malherbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"810_CR1","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/j.jcf.2022.10.007","volume":"22","author":"MD AMARAL","year":"2023","unstructured":"Amaral MD, Harrison PT (2023) Development of novel therapeutics for all individuals with CF (the future goes on). J Cyst Fibros 22:S45\u2013S49","journal-title":"J Cyst Fibros"},{"key":"810_CR2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1089\/gte.2004.8.431","volume":"8","author":"MJH BAARS","year":"2004","unstructured":"Baars MJH, Henneman L, Ten Kate LP (2004) Preconceptional cystic fibrosis carrier screening: opinions of general practitioners, gynecologists, and pediatricians in the Netherlands. Genet Test 8:431\u2013436","journal-title":"Genet Test"},{"key":"810_CR3","doi-asserted-by":"crossref","unstructured":"Burgener EB, Cornfield DN (2023) Delivering a new future for people with cystic fibrosis. Pediatrics, 152","DOI":"10.1542\/peds.2023-062985"},{"key":"810_CR4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ymthe.2021.01.010","volume":"29","author":"SH CHOI","year":"2021","unstructured":"Choi SH, Engelhardt JF (2021) Gene therapy for cystic fibrosis: lessons learned and paths forward. Mol Ther 29:428\u2013430","journal-title":"Mol Ther"},{"key":"810_CR5","unstructured":"Cowling N (2024) Private healthcare in South Africa - statistics and facts [Online]. Available: statistica.com\/topics\/11421\/private-healthcare-in-South-Africa\/#topicOverview. Accessed 28 Apr 2024"},{"key":"810_CR6","first-page":"37","volume":"38","author":"L DA SILVA FILHO","year":"2021","unstructured":"Da Silva Filho L, Zampoli M, Cohen-Cymberknoh M, Kabra SK (2021) Cystic fibrosis in low and middle-income countries (LMIC): A view from four different regions of the world. Paediatr Respir Rev 38:37\u201344","journal-title":"Paediatr Respir Rev"},{"key":"810_CR7","doi-asserted-by":"publisher","first-page":"5943","DOI":"10.1111\/jcmm.17605","volume":"26","author":"ACV DE MELO","year":"2022","unstructured":"De Melo ACV, De Souza KSC, Da Silva HPV, Maia JMC, Dantas VM, Bezerra JF, De Rezende AA (2022) Screening by high-throughput sequencing for pathogenic variants in cystic fibrosis: benefit of introducing personalized therapies. J Cell Mol Med 26:5943\u20135947","journal-title":"J Cell Mol Med"},{"key":"810_CR8","doi-asserted-by":"crossref","unstructured":"Deignan JL, Guo Greggargrodyww, Kearney MH, Raraigh Hmonaghankg, Zepeda-Mendoza Kstaylorj, Ziats CJ, C., documents@acmg.net AB O. D. E. A. 2023. Updated recommendations for CFTR carrier screening: A position statement of the American college of medical genetics and genomics (ACMG). Genet Med, 25, 100867","DOI":"10.1016\/j.gim.2023.100867"},{"key":"810_CR9","unstructured":"Department of Health (2021) Clinical guidelines for genetics services 2021. Pretoria"},{"key":"810_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1569-1993(01)00008-X","volume":"1","author":"JAD DODGE","year":"2002","unstructured":"Dodge JAD, E (2002) CF or not CF? That is the question. J Cyst Fibros 1:3\u20134","journal-title":"J Cyst Fibros"},{"key":"810_CR11","doi-asserted-by":"crossref","unstructured":"Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Rock Derichsnhowenstinemmccolleysa, Rosenfeld M, Sermet-Gaudelus M, I., Southern, K. W., Marshall, B. C., Sosnay PR (2017) Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation. J Pediatr, 181S, S4-S15 e1","DOI":"10.1016\/j.jpeds.2016.09.064"},{"key":"810_CR12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1542\/peds.23.3.545","volume":"23","author":"LE GIBSON","year":"1959","unstructured":"Gibson LE, Cooke RE (1959) A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 23:545\u2013549","journal-title":"Pediatrics"},{"key":"810_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1034\/j.1399-0004.2001.590106.x","volume":"59","author":"A GOLDMAN","year":"2001","unstructured":"Goldman A, Labrum R, Claustres M, Desgeorges M, Guittard C, Wallace A, Ramsay M (2001) The molecular basis of cystic fibrosis in South Africa. Clin Genet 59:37\u201341","journal-title":"Clin Genet"},{"key":"810_CR14","unstructured":"Government of South Africa (2013) Act 4 of 2013 The Protection of Personal Information Act. Cape Town"},{"key":"810_CR15","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/S0140-6736(23)01608-2","volume":"402","author":"SY GRAEBER","year":"2023","unstructured":"Graeber SY, Mall MA (2023) The future of cystic fibrosis treatment: from disease mechanisms to novel therapeutic approaches. Lancet 402:1185\u20131198","journal-title":"Lancet"},{"key":"810_CR16","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jcf.2022.01.009","volume":"21","author":"J GUO","year":"2022","unstructured":"Guo J, Garratt A, Hill A (2022) Worldwide rates of diagnosis and effective treatment for cystic fibrosis. J Cyst Fibros 21:456\u2013462","journal-title":"J Cyst Fibros"},{"key":"810_CR17","first-page":"92","volume":"80","author":"HW HITZEROTH","year":"1991","unstructured":"Hitzeroth HW, Petersen EM, Herbert, J., Denter M (1991) Preventing cystic fibrosis in the RSA. S Afr Med J 80:92\u201398","journal-title":"S Afr Med J"},{"key":"810_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jcf.2005.10.002","volume":"5","author":"V KAPOOR","year":"2006","unstructured":"Kapoor V, Kabra Shastriss, Ramachandran Mkabrask, Balakrishnan Varoras, P., Deorari, A. K., Paul VK (2006) Carrier frequency of F508del mutation of cystic fibrosis in Indian population. J Cyst Fibros 5:43\u201346","journal-title":"J Cyst Fibros"},{"key":"810_CR20","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1126\/science.2570460","volume":"245","author":"B KEREM","year":"1989","unstructured":"Kerem B, Markiewicz Rommensjmbuchananja, Chakravarti DCOXTK, Buchwald A, M., TSUI LC (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245:1073\u20131080","journal-title":"Science"},{"key":"810_CR21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12967-021-03099-4","volume":"19","author":"JA LEE","year":"2021","unstructured":"Lee JA, Cho A, Huang EN, Xu Y, Quach H, Hu, J., Wong AP (2021) Gene therapy for cystic fibrosis: new tools for precision medicine. J Transl Med 19:452","journal-title":"J Transl Med"},{"key":"810_CR22","doi-asserted-by":"crossref","unstructured":"Malherbe C, Aldous (2015) Need for services for the care and prevention of congenital disorders in South Africa as the Cou","DOI":"10.7196\/SAMJ.9136"},{"key":"810_CR23","doi-asserted-by":"crossref","unstructured":"Malherbe HL, Carrihill Bonhamj, Chetty M, Dercksen Kconradieeh, Goeiman M, Mckerrow Hgomesmcmklopperb, Pillay Npadillac, Roussot TS, Satekge B, Urban TM, Van Der Watt M, Vreede G, Webster H, D., Zampoli, M., Vorster BC (2024) Newborn screening in South africa: the past, present, and plans for the future. Rare Disease Orphan Drugs J, 3","DOI":"10.20517\/rdodj.2023.49"},{"key":"810_CR24","first-page":"135","volume":"26","author":"A MISHRA","year":"2005","unstructured":"Mishra A, Greaves R, Massie J (2005) The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era. Clin Biochem Rev 26:135\u2013153","journal-title":"Clin Biochem Rev"},{"key":"810_CR25","volume-title":"National health laboratory service act 37 of 2000","author":"NATIONAL DEPARTMENT OF HEALTH","year":"2000","unstructured":"National Department of Health (2000) National health laboratory service act 37 of 2000. Pretoria, South Africa"},{"key":"810_CR26","unstructured":"Nngwe Project (2024) Nngwe Project - One life matters [Online]. Potchefstroom, South Africa: Nngwe. Available: https:\/\/nngwe.org.za\/. Accessed 23 Nov 2024"},{"key":"810_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1136\/jmg.36.1.41","volume":"36","author":"C PADOA","year":"1999","unstructured":"Padoa C, Goldman A, Jenkins T, Ramsay M (1999) Cystic fibrosis carrier frequencies in populations of African origin. J Med Genet 36:41\u201344","journal-title":"J Med Genet"},{"key":"810_CR28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s12291-010-0091-1","volume":"25","author":"R PRASAD","year":"2010","unstructured":"Prasad R, Sharma H, Kaur G (2010) Molecular basis of cystic fibrosis disease: an Indian perspective. Indian J Clin Biochem 25:335\u2013341","journal-title":"Indian J Clin Biochem"},{"key":"810_CR29","unstructured":"Spotlight (2024) Fight not yet over as case against Vertex is dropped after cystic fibrosis medicine price cut. In: Sect.\u00a027 (ed.) In-depth, public interest health journalism. South Africa"},{"key":"810_CR30","volume-title":"Mid-year population estimates","author":"STATISTICS SOUTH AFRICA","year":"2024","unstructured":"Statistics South Africa (2024) Mid-year population estimates. In: AFRICA, S. S. (ed.). Pretoria, South Africa"},{"key":"810_CR31","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/gim.2015.157","volume":"18","author":"C STEWART","year":"2016","unstructured":"Stewart C, Pepper MS (2016) Cystic fibrosis on the African continent. Genet Med 18:653\u2013662","journal-title":"Genet Med"},{"key":"810_CR32","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.1038\/s41598-024-57513-0","volume":"14","author":"XH TO-MAI","year":"2024","unstructured":"To-Mai XH, Nguyen HT, Nguyen-Thi TT, Nguyen TV, Nguyen-Thi MN, Thai, K. Q., Lai, M. T., Nguyen TA (2024) Prevalence of common autosomal recessive mutation carriers in women in the Southern Vietnam following the application of expanded carrier screening. Sci Rep 14:7461","journal-title":"Sci Rep"},{"key":"810_CR33","doi-asserted-by":"publisher","first-page":"624","DOI":"10.7196\/SAMJ.2018.v108i8.13225","volume":"108","author":"J VAN RENSBURG","year":"2018","unstructured":"Van Rensburg J, Alessandrini M, Stewart C, Pepper MS (2018) Cystic fibrosis in South africa: A changing diagnostic paradigm. S Afr Med J 108:624\u2013628","journal-title":"S Afr Med J"},{"key":"810_CR34","unstructured":"Vertex Pharmaceuticals Inc (2024) Available: https:\/\/www.trikafta.com\/. Accessed 2 Dec 2024"},{"key":"810_CR35","doi-asserted-by":"crossref","unstructured":"Waldman S, Backenroth D, Flohr Harneye, Buckley Sneffnc, Fridman GM, Akbari H, Rohland A, Mallick N, Cano Nistal Solaldeicooperllomesalipsonj, Atzmon Jyujbarzilainpeteri, Ostrer G, Lencz H, Lammerhirt Tmaruvkaye, Rutgers Mbeidera, L. V., Renson, V., Prufer, K. M., Schiffels, S., Ringbauer, H., Sczech, K., Carmi, S., Reich D (2022) Genome-wide data from medieval German Jews show that the Ashkenazi founder event pre-dated the 14th century. Cell, 185, 4703\u20134716 e16","DOI":"10.1016\/j.cell.2022.11.002"},{"key":"810_CR36","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12687-024-00721-y","volume":"15","author":"S WALTERS","year":"2024","unstructured":"Walters S, Aldous C, Malherbe H (2024) Knowledge, attitudes, and practices of primary healthcare practitioners in low- and middle-income countries: a scoping review on genetics. J Community Genet 15:461\u2013474","journal-title":"J Community Genet"},{"key":"810_CR38","first-page":"288","volume":"96","author":"T WESTWOOD","year":"2006","unstructured":"Westwood T, Brown R (2006) Cystic fibrosis in black patients: Western cape experiences. S Afr Med J 96:288\u2013289","journal-title":"S Afr Med J"},{"key":"810_CR37","unstructured":"Westwood ATR IJ (1996) Cystic fibrosis and Kwashiorkor. S Afr Med J"},{"key":"810_CR40","unstructured":"World Health Organisation (2024) Targets of Sustainable Developmental Goal3 to ensure healthy lives and promote well-being for all at all ages [Online]. World Health Organization,. Available: https:\/\/www.who.int\/europe\/about-us\/our-work\/sustainable-development-goals\/targets-of-sustainable-development-goal-3. Accessed 3 Dec 2024"},{"key":"810_CR41","unstructured":"World Health Organization (2004) The molecular genetic epidemiology of cystic fibrosis. Report of a joint meeting of WHO\/ECFTN\/ICF (M) A\/ECFS. Geneva, WHO"},{"key":"810_CR39","unstructured":"World Health Assembly (2024) Seventy-seventh world health assembly resolution 77.5. Accelerate progress towards reducing maternal, newborn and child mortality in order to achieve sustainable development goal targets 3.1 and 3.2"},{"key":"810_CR45","unstructured":"Zampoli ME (2017) The South African Cystic Fibrosis Consensus Guidelines"},{"key":"810_CR43","unstructured":"Zampoli MVJ, Frauendorf M and the CF Steering Committee (2021a) South African cystic fibrosis patient registry report 2021. SACFA"},{"key":"810_CR42","doi-asserted-by":"crossref","unstructured":"Zampoli M, Frauendorf Verstraetej, Workman Mkassanjeer, Morrow LBM, Zar HJ (2021b) Cystic fibrosis in South africa: spectrum of disease and determinants of outcome. ERJ Open Res 7","DOI":"10.1183\/23120541.00856-2020"},{"key":"810_CR111","unstructured":"Zampoli M, Verstraete J, Frauendorf M, and the CF Steering Committee (2024) South African cystic fibrosis registryannual report. https:\/\/sacfa.org.za\/"}],"container-title":["Journal of Community Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12687-025-00810-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12687-025-00810-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12687-025-00810-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:13:21Z","timestamp":1761707601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12687-025-00810-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["810"],"URL":"https:\/\/doi.org\/10.1007\/s12687-025-00810-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6247428\/v1","asserted-by":"object"}]},"ISSN":["1868-6001"],"issn-type":[{"value":"1868-6001","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical clearance was obtained from the University of Kwa-Zulu Natal (BFC222\/18). Reconfirmation of the use of anonymised patient data was received from the laboratory\u2019s chief operating officer in 2025.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical consideration"}},{"value":"The Ampath Laboratories chief operating officer approved the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Sarah Walters, Colleen Aldous, and Helen Malherbe declare no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}